An in vitro study of the effect of 5-ALA-mediated photodynamic therapy on oral squamous cell carcinoma
Authors:
Open Access
- 16 September 2020
- journal article
- research article
- Published by Springer Nature in BMC Oral Health
- Vol. 20 (1) , 1-6
Abstract
Background: The primary aim of this study was to observe the effect of 5-ALA-mediated photodynamic therapy on oral squamous cell carcinoma in vitro. Methods: SCC25 cells were divided into the observation group and the blank control group. Different concentrations of 5-ALA and SCC25 cells were co-incubated for different times, and the concentration of protoporphyrin IX was detected by flow cytometry. SCC25 cells were divided into the 5-ALA group (100 mg/L), the laser irradiation group alone, the 5-ALA plus laser irradiation group, and the blank control group (0 mg/L 5-ALA), and the methyl thiazolyl tetrazolium (MTT) solution method was used (each group was incubated for 4, 8 and 12 h in turn). The cell survival rate was calculated. Using annexin V-fluorescein isothiocyanate/propidium iodide method, the apoptosis of SCC25 cells was detected by flow cytometry. Results: The level of protoporphyrin IX in SCC25 cells increased with increased concentrations of 5-ALA and length of incubation. However, after 12 h, protoporphyrin IX level in SCC25 cells was gradually stabilized, and similar effect was obtained with 100 mg/L or more 5-ALA, indicating that the level of protoporphyrin IX in SCC25 cells was determined by 5-ALA concentration and incubation time. 5-ALA plus laser irradiation exerted an inhibitory effect on the growth of SCC25 cells, which was highly associated with drug dose and incubation time. Compared with the control group, laser irradiation alone or 5-ALA alone had no effect on the apoptosis of SCC25 cells. Different concentrations of 5-ALA combined with laser irradiation showed a remarkable effect of apoptosis, and a higher apoptosis rate was seen with higher drug concentrations. Conclusion: 5-ALA-mediated photodynamic therapy affects the growth of SCC25 cells in vitro, which may provide a new idea for the clinical treatment of oral squamous cell carcinoma.Keywords
This publication has 17 references indexed in Scilit:
- 5-Aminolevulinic acid fermentation using engineered Saccharomyces cerevisiaeMicrobial Cell Factories, 2019
- Severe and Prolonged Hypotension After Oral 5-Aminolevulinic Acid Administration in a Patient With End-Stage Renal Disease Undergoing Transurethral Resection of a Bladder Tumor: A Case ReportA&A Practice, 2019
- 5-Aminolevulinic acid-induced severe hypotension during transurethral resection of a bladder tumor: a case reportJA Clinical Reports, 2019
- Photodynamic Therapy Mediated by 5‐aminolevulinic Acid Promotes the Upregulation and Modifies the Intracellular Expression of Surveillance Proteins in Oral Squamous Cell CarcinomaPhotochemistry and Photobiology, 2018
- Skin burn related to pulse oximetry during photodynamic therapy using talaporfin sodiumJA Clinical Reports, 2018
- A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neckAnnals of Oncology, 2014
- Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)Annals of Oncology, 2014
- Using 5-Aminolevulinic Acid and Pulsed Dye Laser for Photodynamic Treatment of Oral LeukoplakiaJAMA Otolaryngology–Head & Neck Surgery, 2011
- Fluorescence Analysis of Oral Squamous Cell Carcinoma with 5-aminolevulinic Acid LabelingTHE JOURNAL OF THE STOMATOLOGICAL SOCIETY,JAPAN, 2009
- Topical 5-Aminolevulinic Acid Mediated Photodynamic Therapy of Superficial Basal Cell Carcinoma Using Two Light Fractions with a Two-hour Interval: Long-term Follow-upActa Dermato-Venereologica, 2006